Watch these on-demand webinars to learn why Thermo Fisher Scientific is the leading single-source supplier for your COVID-19 testing needs.
Responding to SARS-CoV-2 Variants, such as Omicron: Detection and Surveillance
The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion
Molecular Multi-Target Assay Design Coupled with Follow-Up Testing for SARS-CoV-2 Mutations
The importance of simultaneously detecting and differentiating SARS-CoV-2 and influenza during flu season
This event features a product with Emergency Use Authorization. Verify local availability.
Test and differenciate COVID-19, Flu A/B, and RSV with one assay
This event features a product with CE-IVD certification. Verify local availability.
How to Detect New SARS-CoV-2 Mutations
Throughout the current global crisis, SARS-CoV-2 has continued to mutate. Discover the importance of these emerging variants and the importance testing plays in the on-demand webinars below.
Molecular Multi-Target Assay Design Coupled with Follow-Up Testing for SARS-CoV-2 Mutations
Alan McNally, PhD, Disease Lead for the Milton Keynes Lighthouse Lab UK
Emmanuel André, MD, PhD, Co-Director Infectious Diseases Centre, University Hospital of Leuven
- The story of detecting B.1.1.7 (UK variant) from a world-leading epidemiologist
- The importance of early detection of viral variants and the impact of on global response efforts
- Molecular diagnostic assay design principles to safeguard against unexpected mutations and to monitor for early indicators of emerging variants
- The S-gene advantage with B.1.1.7 and the value of a targeted mutation panel as a follow-up test to identify a suspected variant
Emerging SARS-CoV-2 Mutations: Impact on TaqPath Assay Performance and its Clinical Implications
Peter De Hoff, PhD, Project Scientist, Department of Reproductive Medicine, Sanford Consortium for Regenerative Medicine, UC San Diego
- Automation and miniaturization of clinical SARS-CoV-2 PCR testing
- Emerging SARS-CoV-2 mutations: Impact on TaqPath assay performance and the implications
Molecular Testing, Strain Identification and Quality Control Strategies for COVID-19 Testing
Manohar R. Furtado, PhD, Director R&D, Genetic Testing Solutions, Thermo Fisher Scientific
- The importance of testing to lower transmission rates and contain pandemics
- How mutations emerge and the effect of mutations on SARS-CoV-2 detection assays
- How to quickly identify emerging mutations and variants
Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs
Stephen S. Morse, PhD, Columbia University Medical Center
Matthew Avenarius, PhD, Ohio State University Wexner Medical Center
Manoj Ghandi, PhD, Sr. Director, Medical Affairs, Thermo Fisher Scientific
- An update on the trending variants and explain the risks of the rise of escape mutants
- Best practices to establish both global and local surveillance programs
Testing remains critically important in the fight against COVID-19. As the leader in COVID-19 testing, Thermo Fisher Scientific continues to produce innovative solutions to meet the demands. Watch the on-demand webinars below to see the products in action.
TaqPath COVID-19 tests
Putting the Applied Biosystems TaqPath COVID-19 kit to the test: clinical performance against the competition
Dr. Ninad Mehta, Medical Microbiology, ARUP Laboratories
- Real-world clinical performance of the TaqPath COVID-19 diagnostic test as compared to two other SARS-CoV-2 molecular diagnostic technologies
- Thermo Fisher Scientific's expanding COVID-19 testing portfolio
Responding to the COVID-19 Outbreak: Global Clinical Performance and Development of the Applied Biosystems TaqPath COVID-19 Assay
Paul A. Granato, PhD, DABMM, FAAM, Professor Emeritus of Pathology at SUNY Upstate Medical University Director of Microbiology at Laboratory Alliance of Central New York
- Real-world clinical performance of the TaqPath COVID-19 diagnostic test
- How Thermo Fisher Scientific responded to the SARS-CoV-2 outbreak in the early days of 2020
Clinical Laboratory Experience with TaqPath COVID-19 Testing
Scott Hunicke-Smith, PhD, Scientific Director, Clinical Pathology Laboratories
- How a large reference laboratory operationalized the use of the TaqPath COVID-19 test
- How one lab manages of supply chain, preanalytical throughput, analytical throughput, and extreme variances in COVID-19 testing demand
Thermo Fisher COVID-19 portfolio of tests
COVID-19 Diagnostics Testing Solutions Addressing Challenges and Pain Points in the Laboratory
Peter Friebe, PhD, Sr Manager, Molecular Biology, Genetic Testing Solutions, Thermo Fisher Scientific
- Thermo Fisher’s complete solution to COVID-19 testing
- How automation can vastly increase throughput
After the Surge: Driving Sample Processing Efficiency of COVID-19 Samples
Weston Hymas, R&D Scientist, ARUP
Manohar R. Furtado, PhD, Director R&D,Genetic Testing Solutions, Thermo FisherScientific
- How a SARS-CoV-2 sample pooling protocol can be used to exponentially increase testing efficiency
- How this method can be implemented in labs for routine processing of samples from populations with low infection rates
As employees transition back into the physical workplace, employers are grappling with so many questions pertaining to safety and health for both their employees and their communities. Watch the on-demand webinars below to find the solution that meets your workplace needs.
Overview of COVID-19 Workplace Testing
Mark Stevenson, Executive Vice President and Chief Operating Officer, Thermo Fisher Scientific
Alan Wu, Ph.D., Professor, Lab Medicine UCSF; Co-Core Lab Director, Zuckerberg San Francisco General Hospital
Daniella Cramp, President, Instrument and Enterprise Solutions, Thermo Fisher Scientific
Julia Cheek, CEO and Founder, Everlywell
- Learn about the difference between diagnostic and antibody testing
- Gain understanding of different testing modalities to understand what would work best for your organization
- Discuss the value and rationale for implementing testing in the workplace
- Hear about Thermo Fisher's and Everlywell’s end-to-end testing solution
Safety and well-being in the workplace
Lisa Britt, Senior Visce President and Chief Human Resources Officer, Thermo Fisher Scientific
Matt Willmon, Sr. Director, Compensation, Thermo Fisher Scientific
Daniella Cramp, President, Instrument and Enterprise Solutions, Thermo Fisher Scientific
- Discuss the value and rationale for implementing COVID-19 testing in the workplace
- Hear real-world strategies on workplace testing and policies
- Gain understanding of Everlywell's turn-key resources for sample collection, test reporting, and result-related actions
- Share insights on best practices for communicating and implementing a testing program
COVID-19 epidemiology and workplace testing strategies
Kyle Fowler, Vice President, COVID-19 Project Management, LSG, Thermo Fisher Scientific
Alan Sachs, MD, PhD, Chief Scientific Officer, Thermo Fisher Scientific
Judd Walson, MD, MPH, Professor of Global Health, Medicine, Pediatrics and Epidemiology, University of Washington
- Describe screening and surveillance approaches to help guide back-to-work task forces
- Discuss the latest understanding of SARS-CoV-2 infection in an individual and in a population
- Describe screening and surveillance approaches to help guide back-to-work task forces
- Provide considerations for different testing strategies
